Basic Information
Basic information for MIR9-3HG-212-21aa-1
Peptide Name MIR9-3HG-212-21aa-1
Genome Position chr15:89397778-89397840[+]
Species Human
Peptide Sequence MGCGCRWYTHFTDEDTEAQKS
Peptide Length 21
Unique No (MIR9-3HG-201-21aa-1,MIR9-3HG-213-21aa-1,MIR9-3HG-214-21aa-2,MIR9-3HG-218-21aa-2,MIR9-3HG-219-21aa-2,MIR9-3HG-220-21aa-1,MIR9-3HG-221-21aa-1,MIR9-3HG-222-21aa-2,MIR9-3HG-226-21aa-3,MIR9-3HG-227-21aa-2,MIR9-3HG-233-21aa-2,MIR9-3HG-241-21aa-2,MIR9-3HG-246-21aa-3,MIR9-3HG-247-21aa-1,MIR9-3HG-251-21aa-2,MIR9-3HG-252-21aa-3,MIR9-3HG-253-21aa-2)
Grand Average of Hydropathicity -1.119
Relative Molecular Mass 2826.09
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000654079;MIR9-3HG-212
Transcript Length 4019
Coding Ability 0.521
DNA Sequence Corresponding to Peptide ATGGGGTGTGGGTGTCGTTGGTACACCCATTTTACAGATGAGGACACCGAGGCCCAGAAAAGT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :